Open access · OA
via Europe PMC
Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies.
Suwanprakorn N, Choi Y, Choi YS, Yoo HJ, Yang SG.
Biomolecules & therapeutics · 2026
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Cell culture / in vitro
Review
Abstract
Idiopathic pulmonary fibrosis is a progressive and fatal lung disease characterized by irreversible tissue scarring, structural distortion, and declining respiratory function. Although currently approved antifibrotic therapies can slow disease progression, they do not stop or reverse fibrosis, highlighting the need to better understand upstream disease mechanisms. Increasing evidence identifies cellular senescence(definition) as a central biological process linking aging, epithelial cell vulnerability, mitochondrial dysfunction(definition), and abnormal tissue repair in pulmonary fibrosis. Senescent epithelial and mesenchymal cells remain metabolically active and release a broad array of secreted factors that promote fibroblast activation, persistence of contractile cells, and excessive matrix deposition. Recent advances using single-cell and three-dimensional culture approaches further reveal the accumulation of transitional epithelial cell states that fail to complete normal differentiation and instead perpetuate fibrotic remodeling. These findings suggest that senescence represents not merely a consequence of tissue injury, but a self-sustaining driver of disease progression. This review integrates current mechanistic insights into how cellular senescence coordinates epithelial injury, immune dysregulation, and biomechanical feedback to drive lung fibrosis. We also discuss emerging therapeutic strategies that target senescent cells or their downstream signaling pathways, highlighting their potential to complement existing antifibrotic treatments and enable more effective disease modification.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.4062/biomolther.2026.004
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
N, S., Y, C., YS, C., HJ, Y., & SG., Y. (2026). Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. <em>Biomolecules & therapeutics</em>. https://doi.org/10.4062/biomolther.2026.004
Vancouver
N S, Y C, YS C, HJ Y, SG. Y. Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. Biomolecules & therapeutics. 2026. doi:10.4062/biomolther.2026.004.
BibTeX
@article{suwanprakorn2026Cellul,
title = {Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies.},
author = {Suwanprakorn N and Choi Y and Choi YS and Yoo HJ and Yang SG.},
journal = {Biomolecules & therapeutics},
year = {2026},
doi = {10.4062/biomolther.2026.004},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging 2026
Open access · CC-BY
Senescent fibroblasts in aging and pulmonary fibrosis
Diseases (Basel, Switzerland) 2026
Open access · OA
Cellular Senescence in Idiopathic Pulmonary Fibrosis: Molecular Mechanisms, Pathogenic Networks, and Emerging Therapeutic Targets.
Frontiers in Pharmacology 2022
Open access · CC-BY
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Frontiers in Pharmacology 2020
Open access · CC-BY
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
The EMBO Journal 2024
Open access · CC-BY
Cellular senescence, p21, and the path to fibrosis
Frontiers in immunology 2026
Open access · OA